WallStSmart

Innospec Inc (IOSP)vsSherwin-Williams Co (SHW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sherwin-Williams Co generates 1237% more annual revenue ($23.94B vs $1.79B). SHW leads profitability with a 10.9% profit margin vs 6.4%. IOSP appears more attractively valued with a PEG of 0.66. SHW earns a higher WallStSmart Score of 56/100 (C).

IOSP

Buy

54

out of 100

Grade: C-

Growth: 2.7Profit: 5.5Value: 6.3Quality: 8.5
Piotroski: 4/9Altman Z: 4.11

SHW

Buy

56

out of 100

Grade: C

Growth: 5.3Profit: 7.5Value: 5.3Quality: 4.0
Piotroski: 4/9Altman Z: 1.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for IOSP.

SHWUndervalued (+4.8%)

Margin of Safety

+4.8%

Fair Value

$320.70

Current Price

$300.09

$20.61 discount

UndervaluedFair: $320.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

IOSP4 strengths · Avg: 9.5/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.1110/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.668/10

Growing faster than its price suggests

SHW2 strengths · Avg: 9.5/10
Return on EquityProfitability
58.7%10/10

Every $100 of equity generates 59 in profit

Market CapQuality
$73.12B9/10

Large-cap with strong market position

Areas to Watch

IOSP3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
2.8%4/10

2.8% revenue growth

Profit MarginProfitability
6.4%3/10

6.4% margin — thin

EPS GrowthGrowth
-6.9%2/10

Earnings declined 6.9%

SHW4 concerns · Avg: 4.0/10
PEG RatioValuation
2.294/10

Expensive relative to growth rate

P/E RatioValuation
28.5x4/10

Moderate valuation

Price/BookValuation
16.6x4/10

Trading at 16.6x book value

Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : IOSP

The strongest argument for IOSP centers on Price/Book, Debt/Equity, Altman Z-Score. PEG of 0.66 suggests the stock is reasonably priced for its growth.

Bull Case : SHW

The strongest argument for SHW centers on Return on Equity, Market Cap.

Bear Case : IOSP

The primary concerns for IOSP are Revenue Growth, Profit Margin, EPS Growth.

Bear Case : SHW

The primary concerns for SHW are PEG Ratio, P/E Ratio, Price/Book. Debt-to-equity of 3.11 is elevated, increasing financial risk.

Key Dynamics to Monitor

SHW carries more volatility with a beta of 1.16 — expect wider price swings.

SHW is growing revenue faster at 6.8% — sustainability is the question.

IOSP generates stronger free cash flow (9M), providing more financial flexibility.

Monitor SPECIALTY CHEMICALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SHW scores higher overall (56/100 vs 54/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Innospec Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, the rest of North America, the United Kingdom, the rest of Europe, and internationally. The company is headquartered in Englewood, Colorado.

Sherwin-Williams Co

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.

Want to dig deeper into these stocks?